Fatigue and Inspiratory Muscles Training in Patients With Multiple Sclerosis

NCT ID: NCT02726672

Last Updated: 2018-11-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-29

Study Completion Date

2018-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the effect of a training of the inspiratory muscles against resistance at home during 10 weeks in multiple sclerosis patients with a severe disability.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be informed about the study procedures during a follow-up consultation or an hospitalization in a Physical and Rehabilitation Medicine Unit. If they give their informed consent to participate in the study, an investigator will randomize them into one of the 2 arms of the study. This study consists of 3 visits. The first visit (inclusion) is planned at day 0, the second visit 10 weeks later and the third 3 months after day 0. A patient who is randomized in the experimental arm will have to follow 10 weeks of rehabilitation of the inspiratory muscles at home between first and second visit. During this period, investigators will call these patients once a week to assess the compliance with the rehabilitation. The patients who have been randomized in the control group will not follow this rehabilitation program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Respiratory rehabilitation

Respiratory rehabilitation: Powerbreathe training of the inspiratory muscles at home twice a day (2 sessions of 30 inspirations / day) during 10 weeks

Group Type EXPERIMENTAL

respiratory rehabilitation using Powerbreathe

Intervention Type DEVICE

10 minutes 2 times a day : 30 inspirations per session during 10 weeks

control group

No respiratory rehabilitation

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

respiratory rehabilitation using Powerbreathe

10 minutes 2 times a day : 30 inspirations per session during 10 weeks

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with remitting or progressive multiple sclerosis defined by McDonald criteria revised in 2005, with an EDSS between 6 and 7,5
* Aged between 18 and 65 years
* Patients able to maintain the Powerbreathe
* Not to have had a flare-up since at least 6 weeks
* Patients at least 4 weeks since a corticoid bolus
* Patients at least 6 weeks since a botulinum toxin injection
* Patients at least 4 weeks since a pulmonary infection
* Questionnaire EMIF-SEP \>= 55
* Patients given their informed consent
* Patients who benefit or are affiliated to a social security regimen

Exclusion Criteria

* Patients with neurologic antecedents other that multiple sclerosis
* Patients with respiratory disorders other than those induced by multiple sclerosis
* Patients with orthopedic, cardiac, and rheumatologic invalidating antecedents
* Patients with comprehension or cognitive disorders impeding the realization of rehabilitation
* Pregnant women
* Patients under legal guardianship, or safeguard of justice
* Patients participating or planning participate within the 3 months of the study to another clinical research project
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lille Catholic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cécile Donzé, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Group of the Catholic Institute of Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Group of the Catholic Institute of Lille

Lomme, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-A01451-48

Identifier Type: OTHER

Identifier Source: secondary_id

RC-P0043

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.